Home LiteratureArticle Details
PMID: 7903780 Published · ppublish English Case Reports Journal Article

Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Lancet (London, England) ·Vol. 343 ·No. 8889 ·1994-01-08 ·Pages 85-6

Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP

Abstract

We have observed five children with cystic fibrosis, who presented over 2 months, with meconium ileus equivalent that failed to respond to medical management. At surgery, four had a stricture in the ascending colon, and all had histopathological changes of post-ischaemic ulceration repair, with mucosal and submucosal fibrosis. The only common change in the management of these children was a switch from conventional enteric-coated pancreatic enzymes to high-strength products 12-15 months before presentation.

MeSH Terms
Abdominal Pain/etiology Adolescent Child Child, Preschool Colon/pathology Colonic Diseases/etiology,pathology Constriction, Pathologic/chemically induced Cystic Fibrosis/complications,drug therapy Fibrosis/chemically induced Humans Intestinal Obstruction/etiology,pathology Lipase/adverse effects Male Meconium Pancreatic Extracts/adverse effects Pancreatin/adverse effects Pancrelipase
Chemicals
Pancreatic Extracts Pancrelipase Pancreatin Lipase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Smyth R L
Respiratory Unit, Royal Liverpool Children's Hospital, Alder Hey, UK.
van Velzen D
Smyth A R
Lloyd D A
Heaf D P
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1994-01-08
Pages
85-6
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
CommentIn
CommentIn
CommentIn
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com